1-13 of 13
Massimo Zucchetti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 198: The T3R domain of thrombospondin-1 delays tumor growth and improves tumor response to chemotherapy by remodeling the tumor vasculature

Denise Pinessi, Andrea Resovi, Lavinia Morosi, Patrizia Borsotti, Alexander Berndt, Raffaella Giavazzi, Massimo Zucchetti, Giulia Taraboletti
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 198.
https://doi.org/10.1158/1538-7445.AM2019-198
Published: 01 July 2019
View article titled, Abstract 198: The T3R domain of thrombospondin-1 delays tumor growth and improves tumor response to chemotherapy by remodeling the tumor vasculature
Journal Articles

Abstract 3377: Bevacizumab-improved distribution of paclitaxel in ovarian cancer xenografts potentiates antitumor efficacy

Marta Cesca, Lavinia Morosi, Alexander Berndt, Ilaria Fuso Nerini, Alessandra Decio, Massimo Zucchetti, Raffaella Giavazzi
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3377.
https://doi.org/10.1158/1538-7445.AM2016-3377
Published: 15 July 2016
View article titled, Abstract 3377: Bevacizumab-improved distribution of paclitaxel in ovarian cancer xenografts potentiates antitumor efficacy
Journal Articles

Abstract 2670: Exploring the in vitro and in vivo activity of lucitanib in FGFR1-amplified lung cancer models

Ezia Bello, Rosaria Chilà, Federica Guffanti, Monique Zangarini, Laura Ceriani, Massimo Zucchetti, Saba Chaudi, Marie-Jeanne Pierrat, Anne Jacquet-Bescond, Giovanna L.M. Damia
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2670.
https://doi.org/10.1158/1538-7445.AM2014-2670
Published: 01 October 2014
View article titled, Abstract 2670: Exploring the in vitro and in vivo activity of lucitanib in FGFR1-amplified lung cancer models
Journal Articles

Abstract 3289: PTX-008, a dual inhibitor of angiogenesis and tumor cell proliferation, potentiates the antineoplastic activity of targeted therapies in human tumor models

Katiuscia Bonezzi, Roberta Frapolli, Federica Sala, Lucile Astorgues-Xerri, Maria Serova, Eric Raymond, Esteban Cvitkovic, Kay Noel, Paolo Ubezio, Massimo Zucchetti, Maurizio D'Incalci, Raffaella Giavazzi, Giulia Taraboletti
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 3289.
https://doi.org/10.1158/1538-7445.AM2011-3289
Published: 15 April 2011
View article titled, Abstract 3289: PTX-008, a dual inhibitor of angiogenesis and tumor cell proliferation, potentiates the antineoplastic activity of targeted therapies in human tumor models
Journal Articles

Abstract 4388: LipoplatinTM: A less neurotoxic formulation of Cisplatin

Annalisa Canta, Alessia Chiorazzi, Valentina A. Carozzi, Norberto Oggioni, Barbara Sala, Massimo Zucchetti, Guido A. Cavaletti
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 4388.
https://doi.org/10.1158/1538-7445.AM2011-4388
Published: 15 April 2011
View article titled, Abstract 4388: LipoplatinTM: A less neurotoxic formulation of Cisplatin
Journal Articles

Administering gemcitabine as fixed-dose-rate infusion in combination with cisplatin, potentially effective target plasma concentrations are achieved in patients with advanced non-small cell lung cancer

Elena Marangon, Federica Sala, Orazio Caffo, Maurizio D'Incalci, Enzo Galligioni, Stefania Fallani, Stefania Nobili, Maria Cassetta, Enrico Mini, Massimo Zucchetti
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 1560.
Published: 01 May 2007
View article titled, Administering gemcitabine as fixed-dose-rate infusion in combination with cisplatin, potentially effective target plasma concentrations are achieved in patients with advanced non-small cell lung cancer
Journal Articles

Biological Properties of IDN5174, a New Synthetic Camptothecin with the Open Lactone Ring

Giovanni L. Beretta, Giovanna Petrangolini, Michelandrea De Cesare, Graziella Pratesi, Paola Perego, Stella Tinelli, Monica Tortoreto, Massimo Zucchetti, Roberta Frapolli, Ezia Bello, Carla Manzotti, Gabriele Fontana, Ezio Bombardelli, Arturo Battaglia, Cristian Samorì, Franco Zunino
Journal: Cancer Research
Cancer Res (2006) 66 (22): 10976–10982.
https://doi.org/10.1158/0008-5472.CAN-06-2158
Published: 15 November 2006
View article titled, Biological Properties of IDN5174, a New Synthetic Camptothecin with the Open Lactone Ring
Open the PDF for Biological Properties of IDN5174, a New Synthetic Camptothecin with the Open Lactone Ring in another window
Journal Articles

Down-regulation of angiogenic growth factor expression affects vascularization without impairing tumor response to taxane chemotherapy

Marianna Passiu, Daniela Coltrini, Angela Garofalo, Massimo Zucchetti, Antonella Riva, Marco Presta, Raffaella Giavazzi
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 230.
Published: 15 April 2006
View article titled, Down-regulation of angiogenic growth factor expression affects vascularization without impairing tumor response to taxane chemotherapy
Journal Articles

Antitumor activity of a new synthetic camptothecin with the open lacton ring.

Graziella Pratesi, Giovanni L. Beretta, Michelandrea De Cesare, Giovanna Petrangolini, Maria Stella Tinelli, Massimo Zucchetti, Roberta Frapolli, Carla Manzotti, Ezio Bombardelli, Franco Zunino
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1301.
Published: 15 April 2006
View article titled, Antitumor activity of a new synthetic camptothecin with the open lacton ring.
Journal Articles

Pharmacological evaluation of Gemcitabine administered as fixed-dose-rate in combination with cisplatin to patients with non-small-cell lung cancer

Massimo Zucchetti, Orazio Caffo, Antonio Santo, Samuela Binato, Marco Zaffaroni, Maurizio Centonze, Antonio Lucenti, Monica Giovannini, Giuseppe Cartei, Gianluigi Cetto, Maurizio D’Incalci, Enzo Galligioni
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1247.
Published: 01 April 2004
View article titled, Pharmacological evaluation of Gemcitabine administered as fixed-dose-rate in combination with cisplatin to patients with non-small-cell lung cancer
Journal Articles

Complete Protection by High-Dose Dexamethasone against the Hepatotoxicity of the Novel Antitumor Drug Yondelis (ET-743) in the Rat

Sarah Donald, Richard D. Verschoyle, Peter Greaves, Timothy W. Gant, Tina Colombo, Marco Zaffaroni, Roberta Frapolli, Massimo Zucchetti, Maurizio D’Incalci, Daniela Meco, Riccardo Riccardi, Luis Lopez-Lazaro, Jose Jimeno, Andreas J. Gescher
Journal: Cancer Research
Cancer Res (2003) 63 (18): 5902–5908.
Published: 01 October 2003
View article titled, Complete Protection by High-Dose Dexamethasone against the Hepatotoxicity of the Novel Antitumor Drug Yondelis (ET-743) in the Rat
Open the PDF for Complete Protection by High-Dose Dexamethasone against the Hepatotoxicity of the Novel Antitumor Drug Yondelis (ET-743) in the Rat in another window
Journal Articles

IDN5109, a Taxane with Oral Bioavailability and Potent Antitumor Activity

Maria Ines Nicoletti, Tina Colombo, Cosmo Rossi, Caterina Monardo, Stefania Stura, Massimo Zucchetti, Antonella Riva, Paolo Morazzoni, Maria Benedetta Donati, Ezio Bombardelli, Maurizio D’Incalci, Raffaella Giavazzi
Journal: Cancer Research
Cancer Res (2000) 60 (4): 842–846.
Published: 01 February 2000
View article titled, IDN5109, a Taxane with Oral Bioavailability and Potent Antitumor Activity
Open the PDF for IDN5109, a Taxane with Oral Bioavailability and Potent Antitumor Activity in another window
Journal Articles

Pharmacokinetics of Etoposide in Patients with Abnormal Renal and Hepatic Function

Maurizio D'Incalci, Cosmo Rossi, Massimo Zucchetti, Renato Urso, Franco Cavalli, Costantino Mangioni, Yvonne Willems, Cristiana Sessa
Journal: Cancer Research
Cancer Res (1986) 46 (5): 2566–2571.
Published: 01 May 1986
View article titled, Pharmacokinetics of Etoposide in Patients with Abnormal Renal and Hepatic Function
Open the PDF for Pharmacokinetics of Etoposide in Patients with Abnormal Renal and Hepatic Function in another window